迪安诊断
(300244)
| 流通市值：73.56亿 | | | 总市值：91.68亿 |
| 流通股本：5.01亿 | | | 总股本：6.25亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,365,125,686.41 | 12,196,223,734.01 | 9,258,110,867.57 | 6,218,158,526.59 |
| 营业收入 | 2,365,125,686.41 | 12,196,223,734.01 | 9,258,110,867.57 | 6,218,158,526.59 |
| 二、营业总成本 | 2,246,966,921.12 | 11,403,545,691.66 | 8,491,254,006.48 | 5,720,136,627.66 |
| 营业成本 | 1,740,876,331.02 | 8,779,606,550.03 | 6,661,093,418.77 | 4,496,204,136.58 |
| 税金及附加 | 10,168,333.59 | 43,325,165.81 | 29,421,498.33 | 20,158,709.56 |
| 销售费用 | 258,905,714.22 | 1,217,768,951.79 | 876,607,622.37 | 560,495,520.2 |
| 管理费用 | 136,784,132.2 | 858,931,870.6 | 547,061,712.54 | 389,705,071.62 |
| 研发费用 | 57,443,584.55 | 305,880,933.28 | 225,278,980.27 | 154,755,056.79 |
| 财务费用 | 42,788,825.54 | 198,032,220.15 | 151,790,774.2 | 98,818,132.91 |
| 其中:利息费用 | 42,786,490.45 | 203,027,893.07 | 155,361,651.96 | 107,100,319.44 |
| 其中:利息收入 | 3,941,698.06 | 25,668,594.64 | 19,408,685.41 | 15,276,537.86 |
| 加:公允价值变动收益 | 2,565,031.54 | -12,696,720.83 | -15,805,135.25 | -16,151,612.59 |
| 加:投资收益 | -6,532,709.05 | 38,712,506.27 | 9,184,435.86 | 4,965,251.56 |
| 资产处置收益 | -774,268.67 | -1,476,191.11 | 2,478,187.96 | 2,916,160.15 |
| 资产减值损失(新) | -1,414,134.43 | -401,578,630 | 767,410.38 | -2,631,549.9 |
| 信用减值损失(新) | -100,237,182.78 | -483,449,219.1 | -354,350,039.84 | -254,655,991.12 |
| 其他收益 | 11,657,758.55 | 36,695,034.82 | 26,715,565.6 | 15,379,583.16 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 23,423,260.45 | -31,115,177.6 | 435,847,285.8 | 247,843,740.19 |
| 加:营业外收入 | 263,034.82 | 11,348,915.49 | 7,838,016.37 | 7,453,010.29 |
| 减:营业外支出 | 2,972,696.75 | 32,059,988.7 | 19,513,681.76 | 8,856,365.66 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 20,713,598.52 | -51,826,250.81 | 424,171,620.41 | 246,440,384.82 |
| 减:所得税费用 | 16,541,322.46 | 117,406,845.49 | 121,487,823.69 | 73,805,833.42 |
| 六、净利润 | 4,172,276.06 | -169,233,096.3 | 302,683,796.72 | 172,634,551.4 |
| 持续经营净利润 | 4,172,276.06 | -169,233,096.3 | 302,683,796.72 | 172,634,551.4 |
| 归属于母公司股东的净利润 | -21,005,565.65 | -357,277,652.58 | 130,856,888.98 | 71,746,812.52 |
| 少数股东损益 | 25,177,841.71 | 188,044,556.28 | 171,826,907.74 | 100,887,738.88 |
| (一)基本每股收益 | -0.03 | -0.58 | 0.21 | 0.12 |
| (二)稀释每股收益 | -0.03 | -0.58 | 0.21 | 0.12 |
| 八、其他综合收益 | - | 20,871.95 | -1,679.5 | -117.18 |
| 归属于母公司股东的其他综合收益 | - | 20,871.95 | -1,679.5 | -117.18 |
| 九、综合收益总额 | 4,172,276.06 | -169,212,224.35 | 302,682,117.22 | 172,634,434.22 |
| 归属于母公司股东的综合收益总额 | -21,005,565.65 | -357,256,780.63 | 130,855,209.48 | 71,746,695.34 |
| 归属于少数股东的综合收益总额 | 25,177,841.71 | 188,044,556.28 | 171,826,907.74 | 100,887,738.88 |
| 公告日期 | 2025-04-29 | 2025-04-23 | 2024-10-24 | 2024-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |